FIB-4指数与NFS在识别NAFLD进展期纤维化中的比较:一项Meta分析
结果显示两种评分总体性能为弱至中等;单阈值法下FIB-4更利于排除AF、NFS更利于排除AF,双阈值法下FIB-4的不确定结果比例更低。
要点
- FIB-4与NFS识别AF的总体性能仅为弱至中等
- 单阈值法下FIB-4在排除AF方面表现更优,NFS在排除AF方面表现更优
- 双阈值法下FIB-4的不确定结果比例低于NFS
核心结论
- 现有无创工具在NAFLD患者中识别进展期纤维化的性能有限,需优化现有阈值或开发新的无创工具。
研究设计与样本
- 检索4个数据库至2020年12月(CRD42021224766),纳入报告FIB-4与NFS按标准阈值判读、对象为活检证实NAFLD的原始研究。
- 按低阈值、高阈值及双阈值法分别提取真阴性、真阳性、假阴性、假阳性人数,采用随机效应模型估计汇总操作点。
主要发现
- FIB-4与NFS识别进展期纤维化的总体性能均为弱至中等。
- 头对头比较显示,单阈值法下FIB-4在排除AF方面性能更高,NFS在排除AF方面性能更高。
- 双阈值法下FIB-4的不确定结果比例更低。
临床怎么用
- 在活检证实NAFLD的成人门诊患者中,可参考FIB-4与NFS进行纤维化风险分层,但两者识别AF的性能有限,不宜单独作为免除活检的依据。
- 单阈值法下可依目的选择评分:需排除AF时FIB-4与NFS各有侧重;双阈值法下FIB-4可减少不确定结果。
局限性
- 现有无创工具性能有限,需进一步研究优化阈值或开发新工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In subjects with nonalcoholic fatty liver disease (NAFLD), advanced fibrosis (AF) carries the highest risk of adverse liver-related events. To reduce the number of unnecessary biopsies, several noninvasive tools (NITs) for the risk stratification of fibrosis have been developed. We conducted this meta-analysis to assess the performance of the fibrosis-4 index (FIB-4) and NAFLD fibrosis scores (NFS), the 2 most common NITs, for the appropriate selection of subjects with AF for biopsy. METHODS: Four databases were searched until December 2020 (CRD42021224766). Original articles reporting data on the performance of FIB-4 and NFS, interpreted according to standard cutoffs in subjects with biopsy-proven NAFLD, were included. Separate data extractions were performed according to the lower cutoff, the higher cutoff, and the dual threshold approach. The numbers of subjects classified as true-negative, true-positive, false-negative, and false-positive were extracted. Summary operating points were estimated using a random-effects model. RESULTS: Eighteen studies evaluating 12,604 subjects were included. Participants were adult outpatients with biopsy-proven NAFLD or nonalcoholic steatohepatitis. Overall, a weak-to-moderate performance was found for both scores. The head-to-head comparison showed FIB-4 to be associated with a higher performance in ruling in and NFS in ruling out AF in the single threshold approach, whereas, with the dual threshold approach, a lower prevalence of indeterminate findings was found for FIB-4. DISCUSSION: This meta-analysis suggested that currently available NITs have a limited performance in identifying AF among subjects with NAFLD. Further studies are needed to optimize existing thresholds or develop new NITs.
引用
- Castellana M, Donghia R, Guerra V, et al. Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Am J Gastroenterol. 2021. PMID: 34160377. doi:10.14309/ajg.0000000000001337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。